Literature DB >> 85181

Oral Rh treatment for severely immunised mothers.

S J Bierme, M Blanc, M Abbal, A Fournie.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 85181     DOI: 10.1016/s0140-6736(79)91024-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

Authors:  J B Sun; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

2.  Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans.

Authors:  R M Barnes; J K Duguid; F M Roberts; J M Risk; P M Johnson; R Finn; J Hardy; J A Napier; C A Clarke
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

Review 3.  Haemolytic disease of newborn.

Authors:  A Narang; N Jain
Journal:  Indian J Pediatr       Date:  2001-02       Impact factor: 1.967

4.  The kinetics of oral hyposensitization to a protein antigen are determined by immune status and the timing, dose and frequency of antigen administration.

Authors:  H J Peng; M W Turner; S Strobel
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

5.  Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization.

Authors:  A G Lamont; M G Bruce; K C Watret; A Ferguson
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

6.  Abrogation by subsequent feeding of antibody response including IgE, in parenterally immunized mice.

Authors:  S Lafont; C André; F André; J Gillon; M C Fargier
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

7.  Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness.

Authors:  Henk Schonewille; Jon J van Rood; Esther P Verduin; Leo M G van de Watering; Geert W Haasnoot; Frans H J Claas; Dick Oepkes; Enrico Lopriore; Anneke Brand
Journal:  Haematologica       Date:  2018-09-13       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.